NOACs for VTE prevention in patients with lower limb fracture: a systematic review and meta-analysis

Bingbing Wu1, Lili Sun1, Wenying Wu1

  • 1Department of Nursing, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, 1th Shangcheng Avenue, Yiwu, Zhejiang Province, 322000, China.

Abstract

Insights

Novel oral anticoagulants (NOACs) show a reduced risk of deep vein thrombosis (DVT) in patients with lower limb fractures compared to low molecular weight heparin (LMWH). However, no significant differences were found for overall venous thromboembolism (VTE), pulmonary embolism (PE), or major bleeding events.

Area of Science:

  • Orthopaedic Surgery
  • Pharmacology
  • Vascular Medicine

Background:

  • Novel oral anticoagulants (NOACs) are increasingly prescribed for patients undergoing orthopaedic surgery.
  • Venous thromboembolism (VTE) is a significant risk for patients with lower limb fractures.

Purpose of the Study:

  • To evaluate the efficacy and safety of NOACs in preventing VTE in patients with lower limb fractures.
  • To compare NOACs against low molecular weight heparin (LMWH) in this patient population.

Main Methods:

  • A meta-analysis of randomized controlled trials (RCTs) was conducted.
  • Literature search performed across PubMed, Embase, Cochrane Library, and Web of Science databases up to November 27, 2024.
  • Risk of bias assessed using Cochrane Risk of Bias Tool 2.0; data analyzed using RevMan 5.4.1.

Main Results:

  • Five RCTs with 4,092 participants were included.
  • NOACs significantly reduced the incidence of deep vein thrombosis (DVT) (OR=0.48, P=0.04).
  • No significant differences observed for VTE, pulmonary embolism (PE), or major bleeding events.

Conclusions:

  • NOACs demonstrate a potential benefit in reducing DVT risk for lower limb fracture patients.
  • Further research may be needed to confirm efficacy in preventing overall VTE and PE, and to fully assess safety profiles compared to LMWH.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
25
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
25
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
26
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
46
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
43
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
41